Variations in activin receptor, inhibin/activin subunit and follistatin mRNAs in human prostate tumour tissues

British Journal of Cancer

Volumn 82, Issue 1, 2000, Pages 112-117

  Van Schaik, R H N ^a,b   Wierikx, C D J ^a   Timmerman, M A ^a   Oomen, M H ^a   Van Weerden, W M ^a   Van Der Kwast, T H ^a   Van Steenbrugge, G J ^a   De Jong, F H ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Activin; Activin receptor; Follistatin; Inhibin; Prostate cancer

Indexed keywords

ACTIVIN; ACTIVIN RECEPTOR; ANDROGEN; FOLLISTATIN; INHIBIN; INHIBIN A; INHIBIN B; MESSENGER RNA;

ARTICLE; CANCER CELL CULTURE; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE EPITHELIUM; RIBONUCLEASE PROTECTION ASSAY;

EID: 0033988581     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.1999.0886     Document Type: Article

References (37)

1. Batres Y, Zhang Z and Ying SY (1995) Expression of activins and activin receptor messenger RNAs in LNCaP cells, a human prostatic adenocarcinomn cell line. Int J Oncol 6: 1185-1188
2. Cárcamo J, Weis FMB, Ventura F, Wieser R, Wrana JL, Attisano L and Massaguć J (1994) Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor β and activin. Mol Cell Biol 14: 3810-3821
3. Dalkin AC, Gilrain JT, Bradshaw D and Myers CE (1996) Activin inhibition of prostate cancer cell growth: selective actions on androgen-responsive LNCaP cells. Endocrinology 137: 5230-5235
4. Donaldson CJ, Mathews LS and Vale WW (1992) Molecular cloning and binding properties of the human type II activin receptor. Biochem Biophys Res Commun 184: 310-316
5. Erba HP, Gunning P and Kedes L (1986) Nucleotide sequence of the human γ cytoskeletal actin mRNA: anomalous evolution of vertebrate non-muscle actin genes. Nucleic Acids Res 14: 5275-5294
6. Feng ZM, Madigan MB and Chen CLC (1993) Expression of type II activin receptor genes in the male and female reproductive tissues of the rat. Endocrinology 132: 2593-2600
7. Furst BA, Zhang Z and Ying SY (1995) Expression of activin and activin receptors in human prostatic carcinoma cell line DU145. Int J Oncol 7: 239-243
8. Gonzalez-Manchon C and Vale W (1989) Activin-A, inhibin and transforming growth factor-β modulate growth of two gonadal cell lines. Endocrinology 125: 1666-1672
9. Hasenson M, Hartley-Asp B, Kihlfors C, Lundin A, Gustafsson JA and Pousette A (1985) Effect of hormones on growth and ATP content of a human prostatic carcinoma cell line, LNCaP-r. Prostate 7: 183-194
10. Hashimoto M, Kondo S, Sakurai T, Etoh Y, Shibai H and Muramatsu M (1990) Activin/EDF as an inhibitor of neural differentiation. Biochem Biophys Res Commun 173: 193-200
11. Hedger MP, Drummond AE, Robertson DM, Risbridger GP and de Kretser DM (1989) Inhibin and activin regulate ['H]thymidine uptake by rat thymocytcs and 3T3 cells in vitro. Mol Cell Endocrinol 61: 133-138
12. Hildén K, Tuuri T, Erämaa M and Ritvos O (1994) Expression of type II activin receptor genes during differentiation of human K562 cells and cDNA cloning of the human type IIB activin receptor. Blood 83: 2163-2170
13. Hoehn W, Schröder FH, Riemann JF, Joebsis AC and Hermanek P (1980) Human prostatic adenocarcinoma: some characteristics of a serially transplantable line in nude mice (PC 82). Prostate I: 95-104
14. Horoszewicz JS, Leong SS, Kawinski F, Karr JP, Rosenthal H, Chu TM, Mirand EA and Murphy GP (1983) LNCaP model of human prostatic carcinoma. Cancer Res 43: 1809-1818
15. Ilio KY, Sensibar JA and Lee C (1995) Effect of TGF-β1, TGF-α, and EGF on cell proliferation and cell death in rat ventral prostatic epithelial cells in culture. J Androl 16: 482-490
16. McPherson SJ, Thomas TZ, Wang H, Gurusinghe CJ and Risbridger GP (1997) Growth inhibitory response to activin A and B by human prostate tumour cell lines, LNCaP and DU145. J Endocrinol 154: 535-545
17. Mason AJ, Biall HD and Seeburg PH (1986) Structure of two human ovarian inhibins. Biochem Biophys Res Commun 135: 957-964
18. Massagué J (1996) TGFβ signaling: receptors, transducers, and Mad proteins. Cell 85: 947-950
19. Mathews LS (1994) Activin receptors and cellular signaling by the receptor serine kinase family. Endocr Rev 15: 310-325
20. Mayo KE, Cerelli GM, Spiess J, Rivier J, Rosenfeld MG, Evans RM and Vale W (1986) Inhibin A-subunit cDNAs from porcine ovary and human placenta. Proc Natl Acad Sci USA 83: 5849-5853
21. Mellor SL, Richards MG, Pedersen JS, Robertson DM and Risbridger GP (1998) Loss of expression and localization of inhibin α-subunit in high grade prostate cancer. J Clin Endocrin Metab 83: 969-975
22. Risbridger GP, Thomas T, Gurusinghe CJ and McFarlane JR (1996) Inhibin-related proteins in rat prostate. J Endocrinol 149: 93-99
23. Romijn JC, Verkoelen, CF and Schröder FH (1988) Application of the MTT assay to human prostate cancer cell lines in vitro: establishment of test conditions and assessment of hormone-stimulated growth and drug-induced cytostatic and cytotoxic effects. Prostate 12: 99-110
24. Rubin SJ, Hallahan DE, Ashman CR, Brachman DG, Beckett MA, Virudachalam S, Yandell DW and Weichselbaum RR (1991) Two prostate carcinoma cell lines demonstrate abnormalities in tumor suppressor genes. J Surg Oncol 46: 31-36
25. Sambrook J, Fritsch EF and Maniatis T (1989) Molecular Cloning: a Laboratory Manual. Cold Spring Harbor Press: New York
26. ten Dijke P, Ichijo H, Franzén P, Schulz P, Saras J, Toyoshima H, Heldin CH and Miyazono K (1993) Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity. Oncogene 8: 2879-2887
27. ten Dijke P, Franzen P, Yamashita H, Ichijo H, Heldin CH and Miyazono K (1994) Serine/threonine kinase receptors. Prog Growth Factor Res 5: 55-72
28. Thomas TZ, Chapman SM, Hong W, Gurusinghe C, Mellor SL, Fletcher R, Pedersen J and Risbridger GP (1998) Inhibins, activins, and follistatins: expression of mRNAs and cellular localization in tissues from men with benign prostatic hyperplasia. Prostate 34: 34-43
29. van Schaik RHN, Wierikx CDJ, Looijenga LHJ, Oosterhuis JW and de Jong FH (1997) Human testicular germ cell tumours express inhibin subunits, activin receptors and follistatin mRNAs. Br J Cancer 76: 1191-1198
30. van Steenbrugge GJ, van Uffelen CJ, Bolt J and Schröder FH (1991) The human prostatic cancer cell line LNCaP and its derived sublines: an in vitro model for the study of androgen sensitivity. J Steroid Biochcm Mol Biol 40: 207-214
31. van Weerden WM, de Ridder CM, Verdaasdonk CL, Romijn JC, van der Kwast TH, Schröder FH and van Steenbrugge GJ (1996) Development of seven new human prostate tumor xenograft models and their histopathological characterization. Am J Pathol 149: 1055-1062
32. Wang QF, Schneyer AL, Crowley WF and Sluss PM (1996a) Overexpression of follistatin by a human prostate cancer cell line, PC-3. In: 10th International Congress of Endocrinolog, pp. 8823 (Abstract P3-276): San Francisco CA, USA.
33. Wang QF, Tilly KI, Tilly JL, Preffer F, Schneyer AL, Crowley WF, Jr. and Sluss PM (1996b) Activin inhibits basal and androgen-stimulated proliferation and induces apoptosis in the human prostatic cancer cell line, LNCaP. Endocrinology 137: 5476-5483
34. Ying SY, Zhang Z and Xing W (1995) Expression of activin and activin receptors in PC3 human prostatic cancer cells. Int J Oncol 6: 601 -606
35. Ying SY, Zhang Z, Batres Y, Zhao Y, Lin SL and Li G (1997) p53 is involved in the inhibition of cell proliferation mediated by activin A in cultured human prostate cancer LNCaP cells. Jnt J Oncol 11: 591-595
36. Zhang Z, Zheng J, Zhao Y, Li G, Batres Y, Luo MP, Wan M, Ying SY (1997a). Overexpression of activin A inhibits growth, induces apoptosis, and suppresses tumorigenicity in an androgen-sensitive human prostate cancer cell line LNCaP. Int J Oncol 11: 727-736
37. Zhang Z, Zhao Y, Batres Y, Lin MF and Ying SY (1997b) Regulation of growth and prostatic marker expression by activin A in an androgen-sensitive prostate cancer cell line LNCAP. Biochem Biophys Res Commun 234: 362-365